Lin BioScience, Inc. (TPEX:6696)
Taiwan · Delayed Price · Currency is TWD 267.00
-2.00 (-0.74%)
Oct 31, 2025, 2:59 PM CST
Lin BioScience Market Cap
Lin BioScience has a market cap or net worth of 22.09 billion as of October 31, 2025. Its market cap has increased by 191.40% in one year.
Market Cap
22.09B
Enterprise Value
19.40B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
267.00
Market Cap Chart
Since October 8, 2018, Lin BioScience's market cap has increased from 2.92B to 22.09B, an increase of 657.44%. That is a compound annual growth rate of 33.17%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 31, 2025 | 22.09B | 104.30% |
| Dec 31, 2024 | 10.81B | 20.85% |
| Dec 29, 2023 | 8.95B | -28.90% |
| Dec 30, 2022 | 12.58B | -1.94% |
| Dec 30, 2021 | 12.83B | 83.66% |
| Dec 31, 2020 | 6.99B | 284.89% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Oct 8, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 226.45B |
| PharmaEssentia | 181.96B |
| Bora Pharmaceuticals Co., LTD. | 76.71B |
| Lotus Pharmaceutical | 75.87B |
| Lumosa Therapeutics | 34.53B |
| Oneness Biotech | 30.27B |
| Polaris Group | 27.16B |
| Pegavision | 25.74B |